Evaluation of a mental health screening tool to determine the need for psychological interview for patients offered neuromodulation implant therapies for pain.
Maggie Z X Xiao, Kathryn Curtis, Abigail Muere, Hemkumar Pushparaj, Victoria Bains, Yasmine Hoydonckx, Pranab Kumar, Ehtesham Baig, Abeer Alomari, Ryan S D'Souza, Anuj Bhatia
{"title":"Evaluation of a mental health screening tool to determine the need for psychological interview for patients offered neuromodulation implant therapies for pain.","authors":"Maggie Z X Xiao, Kathryn Curtis, Abigail Muere, Hemkumar Pushparaj, Victoria Bains, Yasmine Hoydonckx, Pranab Kumar, Ehtesham Baig, Abeer Alomari, Ryan S D'Souza, Anuj Bhatia","doi":"10.1136/rapm-2025-107507","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Psychological comorbidities can negatively impact outcomes of spinal cord stimulation (SCS) for chronic pain. While psychological assessment is commonly required before SCS implantation, evidence supporting its impact on outcomes is limited, and such assessments may be unnecessary for many patients and contribute to delays in care. Our center implemented a screening tool incorporating validated questionnaires and a mental health checklist to triage the need for formal psychological evaluation. This prospective, observational cohort study compared outcomes of SCS trials and implants between patients who bypassed (fast track: FT) versus those who underwent a formal assessment by a psychologist (AP).</p><p><strong>Methods: </strong>Data were collected from patients undergoing SCS trials between July 2017 and December 2021. The screening tool used thresholds on validated questionnaires assessing anxiety, depression, catastrophizing, and opioid misuse risk, along with a checklist capturing significant anxiety or depression, self-harm, substance abuse, or mental-health-related hospitalization. Patients screening positive underwent an AP; others proceeded directly to trial (FT). 1 year post implantation outcomes were collected, with successful implantation defined as ≥30% pain reduction from baseline.</p><p><strong>Results: </strong>Of 171 patients (114 AP, 57 FT), trial-to-implant rates were similar (72% AP vs 70% FT, p=0.811). The proportion of responders at 1 year post implant was also comparable (53% AP vs 60% FT, p=0.927). Multivariate logistic regression identified that higher baseline pain intensity (adjusted OR (aOR) 0.70, 95% CI 0.53 to 0.92, p=0.011) and use of tricyclic antidepressants (aOR 0.15, 95% CI 0.04 to 0.56, p=0.005) were associated with implant failure, whereas pain duration >10 years was associated with implant success (aOR 3.09, 95% CI 1.06 to 9.02, p=0.039).</p><p><strong>Conclusions: </strong>This screening tool effectively identifies patients who can bypass routine psychological assessment without compromising 1 year SCS outcomes. Implementation can streamline patient flow, reduce wait times, and reserve psychological resources for those who need formal evaluation.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regional Anesthesia and Pain Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/rapm-2025-107507","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Psychological comorbidities can negatively impact outcomes of spinal cord stimulation (SCS) for chronic pain. While psychological assessment is commonly required before SCS implantation, evidence supporting its impact on outcomes is limited, and such assessments may be unnecessary for many patients and contribute to delays in care. Our center implemented a screening tool incorporating validated questionnaires and a mental health checklist to triage the need for formal psychological evaluation. This prospective, observational cohort study compared outcomes of SCS trials and implants between patients who bypassed (fast track: FT) versus those who underwent a formal assessment by a psychologist (AP).
Methods: Data were collected from patients undergoing SCS trials between July 2017 and December 2021. The screening tool used thresholds on validated questionnaires assessing anxiety, depression, catastrophizing, and opioid misuse risk, along with a checklist capturing significant anxiety or depression, self-harm, substance abuse, or mental-health-related hospitalization. Patients screening positive underwent an AP; others proceeded directly to trial (FT). 1 year post implantation outcomes were collected, with successful implantation defined as ≥30% pain reduction from baseline.
Results: Of 171 patients (114 AP, 57 FT), trial-to-implant rates were similar (72% AP vs 70% FT, p=0.811). The proportion of responders at 1 year post implant was also comparable (53% AP vs 60% FT, p=0.927). Multivariate logistic regression identified that higher baseline pain intensity (adjusted OR (aOR) 0.70, 95% CI 0.53 to 0.92, p=0.011) and use of tricyclic antidepressants (aOR 0.15, 95% CI 0.04 to 0.56, p=0.005) were associated with implant failure, whereas pain duration >10 years was associated with implant success (aOR 3.09, 95% CI 1.06 to 9.02, p=0.039).
Conclusions: This screening tool effectively identifies patients who can bypass routine psychological assessment without compromising 1 year SCS outcomes. Implementation can streamline patient flow, reduce wait times, and reserve psychological resources for those who need formal evaluation.
心理合并症会对脊髓刺激(SCS)治疗慢性疼痛的结果产生负面影响。虽然在SCS植入前通常需要进行心理评估,但支持其对结果影响的证据有限,而且对许多患者来说,这种评估可能是不必要的,并且会导致护理延误。我们的中心采用了一种筛选工具,包括有效的问卷和心理健康检查表,以区分是否需要进行正式的心理评估。这项前瞻性、观察性队列研究比较了旁路(快速通道:FT)患者与接受心理学家(AP)正式评估的患者之间SCS试验和植入的结果。方法:收集2017年7月至2021年12月期间接受SCS试验的患者的数据。筛选工具在有效的问卷中使用阈值来评估焦虑、抑郁、灾难化和阿片类药物滥用风险,同时使用清单来捕获显著的焦虑或抑郁、自残、药物滥用或与精神健康相关的住院治疗。筛查阳性的患者接受AP;另一些则直接进入审判程序(FT)。收集植入后1年的结果,植入成功定义为疼痛较基线减少≥30%。结果:171例患者(114例AP, 57例FT)中,试验植入率相似(72% AP vs 70% FT, p=0.811)。植入后1年应答者的比例也具有可比性(53% AP vs 60% FT, p=0.927)。多因素logistic回归发现,较高的基线疼痛强度(调整OR (aOR) 0.70, 95% CI 0.53 ~ 0.92, p=0.011)和使用三环类抗抑郁药(aOR 0.15, 95% CI 0.04 ~ 0.56, p=0.005)与种植失败相关,而疼痛持续时间bbb10年与种植成功相关(aOR 3.09, 95% CI 1.06 ~ 9.02, p=0.039)。结论:该筛查工具可有效识别可绕过常规心理评估而不影响1年SCS预后的患者。实施可以简化患者流程,减少等待时间,并为需要正式评估的人保留心理资源。
期刊介绍:
Regional Anesthesia & Pain Medicine, the official publication of the American Society of Regional Anesthesia and Pain Medicine (ASRA), is a monthly journal that publishes peer-reviewed scientific and clinical studies to advance the understanding and clinical application of regional techniques for surgical anesthesia and postoperative analgesia. Coverage includes intraoperative regional techniques, perioperative pain, chronic pain, obstetric anesthesia, pediatric anesthesia, outcome studies, and complications.
Published for over thirty years, this respected journal also serves as the official publication of the European Society of Regional Anaesthesia and Pain Therapy (ESRA), the Asian and Oceanic Society of Regional Anesthesia (AOSRA), the Latin American Society of Regional Anesthesia (LASRA), the African Society for Regional Anesthesia (AFSRA), and the Academy of Regional Anaesthesia of India (AORA).